Save Sight Now Europe Funds a program from the University of Wisconsin-Madison led by Dr. David Gamm: A Research to Study Gene Editing in Retinal Degeneration.
Save Sight Now Europe has awarded its first grant to the University of Wisconsin-Madison…
News
Enrolling USH1B Patients for the Uni-Rare Natural History study launched by the The Foundation Fighting Blindness: A critical and necessary step for upcoming clinical trials and future therapies.
Uni-Rare is a Natural History Study of vision loss progression. It is a critical…
OHSU confirms first nonhuman primate model of Usher Syndrome.
Researchers now have a model for testing gene therapy as a treatment for a…
The Foundation Fighting Blindness is launching it’s largest natural history study to date.
It will be for 1,500 People with Inherited Retinal Diseases Caused by Rare Mutated…
Save Sight Now Europe is now live!
We are starting a difficult journey, but one that comes from within, from our…
Understanding Usher Syndrome Type 1B
Defining Characteristics & Research Significance Being born severe to profoundly deaf or gradually losing…
The first non-human primate USH1B model is created
Save Sight Now is funding groundbreaking research on Usher syndrome. For the last two…